JP2014527060A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014527060A5 JP2014527060A5 JP2014527246A JP2014527246A JP2014527060A5 JP 2014527060 A5 JP2014527060 A5 JP 2014527060A5 JP 2014527246 A JP2014527246 A JP 2014527246A JP 2014527246 A JP2014527246 A JP 2014527246A JP 2014527060 A5 JP2014527060 A5 JP 2014527060A5
- Authority
- JP
- Japan
- Prior art keywords
- atoms
- disease
- hal
- group
- dementia
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161527323P | 2011-08-25 | 2011-08-25 | |
| US61/527,323 | 2011-08-25 | ||
| PCT/US2012/051785 WO2013028715A1 (en) | 2011-08-25 | 2012-08-22 | Pyrano [3, 2 - d] [1, 3] thiazole as glycosidase inhibitors |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2014527060A JP2014527060A (ja) | 2014-10-09 |
| JP2014527060A5 true JP2014527060A5 (https=) | 2015-10-29 |
| JP5893738B2 JP5893738B2 (ja) | 2016-03-23 |
Family
ID=46759099
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014527246A Active JP5893738B2 (ja) | 2011-08-25 | 2012-08-22 | グリコシダーゼ阻害剤としてのピラノ［３，２−ｄ］［１，３］チアゾール |
Country Status (21)
| Country | Link |
|---|---|
| US (2) | US8884023B2 (https=) |
| EP (1) | EP2748171B1 (https=) |
| JP (1) | JP5893738B2 (https=) |
| KR (1) | KR102008032B1 (https=) |
| CN (1) | CN103930428B (https=) |
| AU (1) | AU2012298949B2 (https=) |
| BR (1) | BR112014004219B1 (https=) |
| CA (1) | CA2845149C (https=) |
| DK (1) | DK2748171T3 (https=) |
| EA (1) | EA022562B1 (https=) |
| ES (1) | ES2568603T3 (https=) |
| HR (1) | HRP20160334T1 (https=) |
| HU (1) | HUE029390T2 (https=) |
| IL (1) | IL231008A (https=) |
| MX (1) | MX358463B (https=) |
| PL (1) | PL2748171T3 (https=) |
| RS (1) | RS54773B1 (https=) |
| SG (1) | SG2014009617A (https=) |
| SI (1) | SI2748171T1 (https=) |
| WO (1) | WO2013028715A1 (https=) |
| ZA (1) | ZA201400387B (https=) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW201249848A (en) * | 2010-11-08 | 2012-12-16 | Merck Sharp & Dohme | Selective glycosidase inhibitors and uses thereof |
| RU2609210C2 (ru) | 2010-12-23 | 2017-01-31 | Алектос Терапьютикс Инк. | Селективные ингибиторы гликозидазы и их применение |
| EP2688899B1 (en) | 2011-03-24 | 2017-02-22 | Alectos Therapeutics Inc. | Selective glycosidase inhibitors and uses thereof |
| EP2691407B1 (en) * | 2011-03-31 | 2017-02-22 | Alectos Therapeutics Inc. | Selective glycosidase inhibitors and uses thereof |
| US9701693B2 (en) | 2011-06-27 | 2017-07-11 | Alectos Therapeutics Inc. | Selective glycosidase inhibitors and uses thereof |
| EP2726468B1 (en) | 2011-06-27 | 2017-04-12 | Alectos Therapeutics Inc. | Selective glycosidase inhibitors and uses thereof |
| BR112013033098B8 (pt) | 2011-06-27 | 2021-03-23 | Alectos Therapeutics Inc | inibidores de glicosidade seletivos e usos dos mesmos |
| ES2568603T3 (es) * | 2011-08-25 | 2016-05-03 | Merck Patent Gmbh | Pirano[3,2-d][1,3]tiazol como inhibidores de glicosidasas |
| EP2890676B1 (en) | 2012-08-31 | 2018-12-05 | Alectos Therapeutics Inc. | Glycosidase inhibitors and uses thereof |
| EP2890675A4 (en) | 2012-08-31 | 2016-01-13 | Alectos Therapeutics Inc | GLYCOSIDASE INHIBITORS AND USES THEREOF |
| KR20150079711A (ko) | 2012-10-31 | 2015-07-08 | 알렉토스 테라퓨틱스 인크. | 글리코시다아제 저해제 및 이의 용도 |
| WO2014100934A1 (en) * | 2012-12-24 | 2014-07-03 | Merck Sharp & Dohme Corp. | Glycosidase inhibitors and uses thereof |
| KR102043337B1 (ko) | 2014-08-28 | 2019-11-11 | 아셰뉴론 에스아 | 글리코시다제 저해제 |
| CN108029215B (zh) * | 2015-09-18 | 2020-10-27 | 东丽株式会社 | 壳体 |
| CA3014572C (en) | 2016-02-25 | 2023-10-03 | Asceneuron S.A. | Acid addition salts of piperazine derivatives |
| AU2017222964B2 (en) | 2016-02-25 | 2020-01-02 | Asceneuron S. A. | Glycosidase inhibitors |
| KR20180132629A (ko) | 2016-02-25 | 2018-12-12 | 아셰뉴론 에스아 | 글리코시다제 저해제 |
| US11261183B2 (en) | 2016-02-25 | 2022-03-01 | Asceneuron Sa | Sulfoximine glycosidase inhibitors |
| US11213525B2 (en) | 2017-08-24 | 2022-01-04 | Asceneuron Sa | Linear glycosidase inhibitors |
| WO2020039027A1 (en) | 2018-08-22 | 2020-02-27 | Asceneuron S. A. | Pyrrolidine glycosidase inhibitors |
| WO2020039029A1 (en) | 2018-08-22 | 2020-02-27 | Asceneuron S. A. | Spiro compounds as glycosidase inhibitors |
| JP7407171B2 (ja) | 2018-08-22 | 2023-12-28 | エースニューロン・ソシエテ・アノニム | グリコシダーゼ阻害剤として有用なピペラジン誘導体のコハク酸付加塩及びフマル酸付加塩 |
| WO2020039028A1 (en) | 2018-08-22 | 2020-02-27 | Asceneuron S. A. | Tetrahydro-benzoazepine glycosidase inhibitors |
| US12565504B2 (en) * | 2019-10-29 | 2026-03-03 | Biogen Ma Inc. | Spirocyclic O-glycoprotein-2-acetamido-2-deoxy-3-d-glucopyranosidase inhibitors |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2599843C (en) * | 2005-03-01 | 2013-08-27 | Simon Fraser University | Selective glycosidase inhibitors, methods of making inhibitors, and uses thereof |
| EP1979360B1 (en) * | 2006-01-30 | 2009-10-14 | Irm Llc | Compounds and compositions as ppar modulators |
| AU2007291870B2 (en) * | 2006-08-31 | 2012-12-06 | Simon Fraser University | Selective glycosidase inhibitors and uses thereof |
| CN107253970A (zh) * | 2006-08-31 | 2017-10-17 | 西蒙·弗雷瑟大学 | 选择性糖苷酶抑制剂及其用途 |
| WO2011140640A1 (en) | 2010-05-11 | 2011-11-17 | Simon Fraser University | Selective glycosidase inhibitors and uses thereof |
| WO2012061972A1 (en) | 2010-11-08 | 2012-05-18 | Alectos Therapeutics Inc. | Selective glycosidase inhibitors and uses thereof |
| US8933040B2 (en) | 2010-11-08 | 2015-01-13 | Craig A. Coburn | Selective glycosidase inhibitors and uses thereof |
| RU2609210C2 (ru) | 2010-12-23 | 2017-01-31 | Алектос Терапьютикс Инк. | Селективные ингибиторы гликозидазы и их применение |
| ES2568603T3 (es) * | 2011-08-25 | 2016-05-03 | Merck Patent Gmbh | Pirano[3,2-d][1,3]tiazol como inhibidores de glicosidasas |
-
2012
- 2012-08-22 ES ES12753341.2T patent/ES2568603T3/es active Active
- 2012-08-22 JP JP2014527246A patent/JP5893738B2/ja active Active
- 2012-08-22 HU HUE12753341A patent/HUE029390T2/en unknown
- 2012-08-22 BR BR112014004219-5A patent/BR112014004219B1/pt active IP Right Grant
- 2012-08-22 SI SI201230534A patent/SI2748171T1/sl unknown
- 2012-08-22 EA EA201490493A patent/EA022562B1/ru not_active IP Right Cessation
- 2012-08-22 WO PCT/US2012/051785 patent/WO2013028715A1/en not_active Ceased
- 2012-08-22 KR KR1020147002525A patent/KR102008032B1/ko active Active
- 2012-08-22 RS RS20160280A patent/RS54773B1/sr unknown
- 2012-08-22 PL PL12753341T patent/PL2748171T3/pl unknown
- 2012-08-22 US US14/131,471 patent/US8884023B2/en active Active
- 2012-08-22 DK DK12753341.2T patent/DK2748171T3/en active
- 2012-08-22 CN CN201280041109.9A patent/CN103930428B/zh active Active
- 2012-08-22 AU AU2012298949A patent/AU2012298949B2/en active Active
- 2012-08-22 EP EP12753341.2A patent/EP2748171B1/en active Active
- 2012-08-22 HR HRP20160334TT patent/HRP20160334T1/hr unknown
- 2012-08-22 CA CA2845149A patent/CA2845149C/en active Active
- 2012-08-22 SG SG2014009617A patent/SG2014009617A/en unknown
- 2012-08-22 MX MX2014002031A patent/MX358463B/es active IP Right Grant
-
2014
- 2014-01-17 ZA ZA2014/00387A patent/ZA201400387B/en unknown
- 2014-02-17 IL IL231008A patent/IL231008A/en active IP Right Grant
- 2014-09-30 US US14/502,213 patent/US9469657B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2014527060A5 (https=) | ||
| JP2019510006A5 (https=) | ||
| HRP20160334T1 (hr) | Pirano [3, 2 - d][1, 3]tiazol kao inhibitori glikozidaze | |
| JP2019506430A5 (https=) | ||
| JP2014503527A5 (https=) | ||
| JP2015512951A5 (https=) | ||
| JP2014511893A5 (https=) | ||
| JP2014506907A5 (https=) | ||
| JP2010522709A5 (https=) | ||
| JP2013056919A5 (https=) | ||
| CN103717571B8 (zh) | 9‑氨基甲基取代的四环素类化合物 | |
| JP2017502961A5 (https=) | ||
| EP2650293A8 (en) | [1,2,4]triazolo[4,3-b][1,2,4]triazine compound, preparation method and use thereof | |
| RU2014112370A (ru) | Фармацевтическая композиция для применения при лечении нейродегенеративного заболевания | |
| HRP20230628T1 (hr) | Primjena i doziranje diaminofenotiazina | |
| JP2015534991A5 (https=) | ||
| JP2015500223A5 (https=) | ||
| CA2826192A1 (en) | Methods and compositions for treating bacterial infections with iron chelators | |
| GEAP201914563A (en) | Compounds having muscarinic receptor antagonist and beta2 adrenergic receptor agonist activity | |
| IN2014MN01756A (https=) | ||
| JP2010522711A5 (https=) | ||
| JP2013518914A5 (https=) | ||
| RU2014153571A (ru) | Фармацевтическая композиция, содержащая производное вербенола, для лечения или профилактики нейродегенеративного заболевания | |
| JP2012505905A5 (https=) | ||
| WO2012031383A1 (zh) | 酰胺类化合物 |